Dr Reddy’s gets USFDA nod for rituximab biosimilar
· thehindubusinessline.com
Dr. Reddy’s Laboratories gains USFDA approval for rituximab biosimilar, enhancing its global biosimilars portfolio and market presence.
Pharma major Dr Reddy’s Laboratories has secured approval from the U.S. Food and Drug Administration (FDA) for its rituximab biosimilar, a biosimilar to Ritux...